Moritani M, Nomura K, Tanahashi T, Osabe D, Fujita Y, Shinohara S, Yamaguchi Y, Keshavarz P, Kudo E, Nakamura N, Yoshikawa T, Ichiishi E, Takata Y, Yasui N, Shiota H, Kunika K, Inoue H, Itakura M
Division of Genetic Information, Institute for Genome Research, The University of Tokushima, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
Diabetologia. 2007 Jun;50(6):1218-27. doi: 10.1007/s00125-007-0631-2. Epub 2007 Apr 6.
AIMS/HYPOTHESIS: In order to identify type 2 diabetes disease susceptibility gene(s) in a Japanese population, we applied a region-wide case-control association test to the 20.4 Mb region between D3S1293 and D3S2319 on chromosome 3p24.3-22.1, supported by linkage to type 2 diabetes and its related traits in Japanese and multiple populations.
We performed a two-stage association test using 1,762 Japanese persons with 485 gene-centric, evenly spaced, common single nucleotide polymorphism (SNP) markers with minor allele frequency >0.1. For mouse studies, total RNA was extracted from various organs of BKS.Cg-+Lepr(db)/+Lepr(db) and control mice, and from MIN6, NIH3T3 and C2C12 cell lines.
We detected a landmark SNP375 (A/G) (rs2051211, p = 0.000046, odds ratio = 1.33, 95% CI 1.16-1.53) in intron 5 of the endonuclease G-like 1 (ENDOGL1) gene. Systematic dense SNPs approach identified a susceptibility linkage disequilibrium (LD) block of 116.5 kb by |D'|, an LD units map and a critical region of 2.1 kb by r (2) in ENDOGL1. A haplotype-based association test showed that an at-risk haplotype is associated with disease status (p = 0.00001). The expression of ENDOGL1 was rather ubiquitous with relatively abundant expression in the brain and also in a pancreatic islet beta cell line. Mouse Endogl1 expression increased in pancreatic islets of hyperglycaemic BKS.Cg-+Lepr(db)/+Lepr(db) mice compared with that in control mice.
CONCLUSIONS/INTERPRETATION: Based on the population genetics, fine mapping of LD block and haplotype analysis, we conclude that ENDOGL1 is a candidate disease-susceptibility gene for type 2 diabetes in a Japanese population. Further analysis in a larger sample size is required to substantiate this conclusion.
目的/假设:为了在日本人群中鉴定2型糖尿病疾病易感基因,我们对3号染色体p24.3 - 22.1上D3S1293和D3S2319之间的20.4 Mb区域进行了全区域病例对照关联测试,该区域在日本及多个群体中与2型糖尿病及其相关性状存在连锁关系。
我们使用1762名日本人进行了两阶段关联测试,这些日本人带有485个以基因为中心、均匀分布、次要等位基因频率>0.1的常见单核苷酸多态性(SNP)标记。对于小鼠研究,从BKS.Cg-+Lepr(db)/+Lepr(db)小鼠和对照小鼠的各种器官以及MIN6、NIH3T3和C2C12细胞系中提取总RNA。
我们在内切核酸酶G样1(ENDOGL1)基因的第5内含子中检测到一个标志性SNP375(A/G)(rs2051211,p = 0.000046,优势比 = 1.33,95%可信区间1.16 - 1.53)。系统密集SNP方法通过|D'|确定了一个116.5 kb的易感连锁不平衡(LD)块,通过r²在ENDOGL1中确定了一个2.1 kb的关键区域。基于单倍型的关联测试表明,一种风险单倍型与疾病状态相关(p = 0.00001)。ENDOGL1的表达相当普遍,在大脑以及胰岛β细胞系中表达相对丰富。与对照小鼠相比,高血糖BKS.Cg-+Lepr(db)/+Lepr(db)小鼠胰岛中的小鼠Endogl1表达增加。
结论/解读:基于群体遗传学、LD块精细定位和单倍型分析,我们得出结论,ENDOGL1是日本人群中2型糖尿病的候选疾病易感基因。需要在更大样本量中进行进一步分析以证实这一结论。